Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Protocols, labeling

Antigen retrieval procedure Selection of primary antibodies Protocol labeling reagents Reagent validation Control selection Technician training/certification Laboratory certification / QA programs... [Pg.21]

Bioassays for microarrays exploit a similar protocol labeled or unlabeled target molecules in a solution sample are brought to interact with the immobilized probe molecules (Fig. 3). Target molecules are commonly labeled with fluorescent tags. [Pg.32]

A good example of a prescriptive approach to quality assessment is the protocol outlined in Figure 15.2, published by the Environmental Protection Agency (EPA) for laboratories involved in monitoring studies of water and wastewater. Independent samples A and B are collected simultaneously at the sample site. Sample A is split into two equal-volume samples, and labeled Ai and A2. Sample B is also split into two equal-volume samples, one of which, Bsf, is spiked with a known amount of analyte. A field blank. Dp, also is spiked with the same amount of analyte. All five samples (Ai, A2, B, Bsf, and Dp) are preserved if necessary and transported to the laboratory for analysis. [Pg.712]

Direct quantitation of receptor concentrations and dmg—receptor interactions is possible by a variety of techniques, including fluorescence, nmr, and radioligand binding. The last is particularly versatile and has been appHed both to sophisticated receptor quantitation and to dmg screening and discovery protocols (50,51). The use of high specific activity, frequendy pH]- or p lj-labeled, dmgs bound to cmde or purified cellular materials, to whole cells, or to tissue shces, permits the determination not only of dmg—receptor saturation curves, but also of the receptor number, dmg affinity, and association and dissociation kinetics either direcdy or by competition. Complete theoretical and experimental details are available (50,51). [Pg.276]

Samples logged into the system are assigned a unique number which is often physically attached to the sample using a bar-code label. The testing protocol is contained in the LIMS and is based on the point in the process from which the sample was taken. This information and the identification of the type of sample enable the LIMS to schedule the testing of the material. [Pg.368]

There are many protocols and different types of platforms available, e.g. GeneChips from Affymetrix, Illumina Bead Arrays, Arrays from Agilent, Applied Biosystems, GE Healthcare, customized spotted cDNA microarrays etc. the basic procedure for a large-scale measurement of gene expression involves the preparation of total or mRNA from the biological sample(s) under investigation (e.g. candidate tissue) and the hybridization of copied labelled RNA or cDNA to the DNA elements on the array surface (Fig. 1). [Pg.526]

An environmental protocol has been developed to assess the significance of newly discovered hazardous substances that might enter soil, water, and the food chain. Using established laboratory procedures and C-labeled 2,3,7,8-tetra-chlorodibenzo-p-dioxin (TCDD), gas chromatography, and mass spectrometry, we determined mobility of TCDD by soil TLC in five soils, rate and amount of plant uptake in oats and soybeans, photodecomposition rate and nature of the products, persistence in two soils at 1,10, and 100 ppm, and metabolism rate in soils. We found that TCDD is immobile in soils, not readily taken up by plants, subject to photodecomposition, persistent in soils, and slowly degraded in soils to polar metabolites. Subsequent studies revealed that the environmental contamination by TCDD is extremely small and not detectable in biological samples. [Pg.105]

Fig. 6.5 Schematic representation of a bioelectronic protocol for detection of DNA hybridization (A) binding of the target to magnetic beads (B) hybridization with CdS-labeled probe (C) dissolution of CdS tag (D) potentiometric stripping detection at a mercury-film electrode. (Reprinted from [136], Copyright 2009, with permission from Elsevier)... Fig. 6.5 Schematic representation of a bioelectronic protocol for detection of DNA hybridization (A) binding of the target to magnetic beads (B) hybridization with CdS-labeled probe (C) dissolution of CdS tag (D) potentiometric stripping detection at a mercury-film electrode. (Reprinted from [136], Copyright 2009, with permission from Elsevier)...
The significance level relates to the risk of designating a chance occurrence as statistically significant. Usually a 5% level is utilized for testing treatment effects. If a p-value of 0.04 is reported for a treatment effect, this means that there is only a 4% chance that the difference in response between the active and control treatments occurred due to chance. Keep in mind, however, that if many tests are run in a trial, it is entirely possible that one or two might be significant due to chance. As an extreme example, consider a study in which 100 statistical tests are run. We would expect five of those tests to show significance with a p-value of 0.05 or less due to chance. Therefore, it is essential to specify the main tests to be run in the protocol. Any tests that are conducted after the trial has been completed should be clearly labeled as post hoc exploratory analyses. [Pg.243]

A protocol must be established and followed for sample preparation, labeling, packaging, shipping, and chain-of-custody procedures. Also, the volume of the samples will be specified by the analytical laboratory depending on the analytical methods to be used and the desired sensitivity. Accordingly, principal attention will be given here to the sampling methods, preparation of the samples for analysis, and QA/QC aspects of both. [Pg.102]

Since the MHLW designated shrimp/prawn and crab for mandatory labeling in June 2008 due to the almost unlimited use of crustacean in the processed foods in Japan and the status as a frequent cause of adverse food reactions in allergic patients, two ELISA methods for the determination of crustacean protein in processed foods have been developed (Seiki et al, 2007 Shibahara et al., 2007) EA test EIA-Crustacean [Nissui] produced by Nissui Pharmaceutical Co., Ltd. and Crustacean Kit [Maruha ] produced by Maruha Nichiro Eoods, Inc. Both kits have been validated according to the Japanese validation protocol (Sakai et al., 2008) and are commercially available. All the commercial ELISA kits are shown in Table 4.9. [Pg.154]

Recurrent is the lack of adequate techniques to assess carbon flows through the plants and microbes into soil organic matter (151). Most important is the development of techniques and protocols to separate rhizosphere from nonrhizosphere soil as well as possibly to facilitate analyses of soil carbon dynamics. The use of carbon isotopes, and, where possible, application of double labeling with C and C, seems inevitable in order to separate the contribution of different substrates to the formation of the soil organic matter pool and to get to an understanding of the ecological advantage of exudates and rhizodeposits. [Pg.186]

Protocols should require documentation of actual application practices and times. Samples of applied pesticides should be collected to document application rates to study sites. The test substance must be applied with typical equipment used for the crop, and the application must be made in accordance with the labeled use. Another variable that impacts such studies is the fact that most landowners have their own application equipment, which increases the variance in actual application rates among fields and may cause differential intra-field heterogeneity in application rates. [Pg.944]

A protocol should be designed to conform as closely as possible to all ERA requirements. The test substance is a typical end-use product and application and agronomic practices accurately reflect the label and normal crop culture in the areas where the study will be conducted. Dislodging leaf material with a surfactant in aqueous... [Pg.962]

Cai M, Huang Y, Sakaguchi K, Clore GM, Gronenborn AM, Craigie R. An efficient and cost-effective isotope labeling protocol for proteins expressed in Escherichia coli. J Biomol NMR 1998 11 97-102. [Pg.90]


See other pages where Protocols, labeling is mentioned: [Pg.417]    [Pg.175]    [Pg.417]    [Pg.175]    [Pg.152]    [Pg.475]    [Pg.521]    [Pg.357]    [Pg.363]    [Pg.391]    [Pg.407]    [Pg.35]    [Pg.766]    [Pg.767]    [Pg.206]    [Pg.181]    [Pg.530]    [Pg.359]    [Pg.341]    [Pg.129]    [Pg.885]    [Pg.544]    [Pg.183]    [Pg.161]    [Pg.140]    [Pg.148]    [Pg.152]    [Pg.204]    [Pg.209]    [Pg.1021]    [Pg.157]    [Pg.297]    [Pg.254]    [Pg.63]    [Pg.75]    [Pg.208]   
See also in sourсe #XX -- [ Pg.113 , Pg.114 , Pg.115 , Pg.116 , Pg.117 , Pg.118 , Pg.119 ]




SEARCH



AMCA-NHS protein labeling protocol

Biocytin hydrazide glycoprotein labeling protocol

Biotin-hydrazide glycoprotein labeling protocol

NHS-LC-biotin protein labeling protocol

© 2024 chempedia.info